Investment Bankers are Circling Europe’s Growing Cannabis Market
Pharmadrug believes that this is yet another positive data point that cannabis investors are increasingly looking towards Europe for new opportunities.
As Bloomberg points out, there are still only a handful of ways Europeans can access marijuana stocks and cannabis investments. With one of 10 German Class I licenses to distribute medical cannabis throughout the E.U., Pharmadrug is strategically positioned in Europe to take advantage of a burgeoning cannabis market.
As Pharmadrug continues to build out its cannabis presence in Germany and the rest of Europe, we offer a compelling opportunity to cannabis investors looking to participate in the region.
For additional details about Pharmadrug and our medical cannabis operations, please get in touch.